VanEck Genomics and Healthcare Innovators UCITS ETF
CURE.DE
#3231
ETF rank
โ‚น1.16 B
Marketcap
๐Ÿ‡ช๐Ÿ‡บ EU
Market
โ‚น1,879
Share price
-0.40%
Change (1 day)
16.15%
Change (1 year)

Expense ratio and fees for VanEck Genomics and Healthcare Innovators UCITS ETF (CURE.DE)

Total Expense Ratio

Total Expense Ratio as of March 2026: 0.35%